New Alzheimer’s Association Special Report Breaks Down How Americans Understand and Support their Brain Health
In recent years, public interest in brain health has increased. So how are Americans understanding brain health information and incorporating it into their own lives? This year, the Alzheimer’s Associ...
25 Elo 37min
Reflecting on 25 Years of the Wisconsin Registry for Alzheimer’s Prevention
Twenty-five years ago, a single participant enrolled in what would become the Wisconsin Registry for Alzheimer's Prevention (WRAP), now one of the largest and longest-running studies of Alzheimer's ri...
12 Elo 35min
How Dementia Caregiving Affects the Spousal Caregiver
Caring for those with dementia represents a major public health challenge, with caregivers, especially spouses, providing long-term, largely unpaid care. With caregiving stress linked to a decline in ...
28 Heinä 39min
Managing the Medicine Cabinet: How Prescriptions Impact Cognition and Brain Health as We Age
Prescription medications, over-the-counter drugs and supplements are incredibly common among older adults, yet many of these routine treatments can unexpectedly impact cognitive function and brain hea...
14 Heinä 35min
Taking a Deep Dive into Subjective Cognitive Decline
Dr. Jessen returns to the podcast to take a deeper dive into subjective cognitive decline (SCD). Aiming to cover everything relating to SCD, Dr. Jessen shares insights in prognosis, risk factors and h...
7 Heinä 17min
Defining Subjective Cognitive Decline
Subjective cognitive decline (SCD) can be one of the earliest noticeable signs of Alzheimer's disease, yet SCD is not yet fully understood. To help us understand more, Dr. Frank Jessen, an expert in t...
30 Kesä 30min
SPRINT to a Healthy Mind: How Blood Pressure Control Affects Brain Health and Dementia Risk
Geriatrician Dr. Mark Supiano joins the podcast to discuss the connection between heart and brain health. Citing multiple clinical trials, he breaks down what these studies and their findings mean for...
18 Kesä 40min
Addressing Cochrane’s Review on Amyloid-Targeting Treatments for Alzheimer’s Disease
Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapies after decades of research and clinical trials. A recent review published by Cochrane, a glob...
4 Kesä 44min
